Open AccessCorticosteroids alleviate adverse events associated with enzalutamide in patients with metastatic castration‑resistant prostate cancer
Author(s) -
Keita Tamura,
Yuto Matsushita,
Hiromitsu Watanabe,
Daisuke Motoyama,
Toshiki Ito,
Takayuki Sugiyama,
Atsushi Otsuka,
Hideaki Miyake
Publication year - 2020
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2020.2013
Subject(s) - enzalutamide , prostate cancer , molecular medicine , medicine , oncogene , adverse effect , cancer , oncology , cancer research , cell cycle , androgen receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom